Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2004 | 1 |
2015 | 2 |
2017 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain.
Cells. 2022 Dec 13;11(24):4027. doi: 10.3390/cells11244027.
Cells. 2022.
PMID: 36552791
Free PMC article.
A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam.
Di Cesare Mannelli L, Maresca M, Farina C, Scherz MW, Ghelardini C.
Di Cesare Mannelli L, et al. Among authors: scherz mw.
Neurotoxicology. 2015 Sep;50:101-7. doi: 10.1016/j.neuro.2015.08.002. Epub 2015 Aug 5.
Neurotoxicology. 2015.
PMID: 26254739
Item in Clipboard
Three different up-titration regimens of ponesimod, an S1P1 receptor modulator, in healthy subjects.
Scherz MW, Brossard P, D'Ambrosio D, Ipek M, Dingemanse J.
Scherz MW, et al.
J Clin Pharmacol. 2015 Jun;55(6):688-97. doi: 10.1002/jcph.467. Epub 2015 Feb 10.
J Clin Pharmacol. 2015.
PMID: 25612299
Clinical Trial.
Item in Clipboard
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.
Di Cesare Mannelli L, Maresca M, Micheli L, Farina C, Scherz MW, Ghelardini C.
Di Cesare Mannelli L, et al. Among authors: scherz mw.
Cancer Chemother Pharmacol. 2017 Dec;80(6):1091-1103. doi: 10.1007/s00280-017-3449-8. Epub 2017 Oct 12.
Cancer Chemother Pharmacol. 2017.
PMID: 29026967
Item in Clipboard
Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines.
Ziltener P, Mueller C, Haenig B, Scherz MW, Nayler O.
Ziltener P, et al. Among authors: scherz mw.
J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):155-68. doi: 10.1081/rrs-120014593.
J Recept Signal Transduct Res. 2002.
PMID: 12503613
Item in Clipboard
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System.
Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, Fischli W, Hess P, Mathys B, Morrison K, Müller C, Müller C, Nayler O, Qiu C, Rey M, Scherz MW, Velker J, Weller T, Xi JF, Ziltener P.
Clozel M, et al. Among authors: scherz mw.
J Pharmacol Exp Ther. 2004 Oct;311(1):204-12. doi: 10.1124/jpet.104.068320. Epub 2004 May 14.
J Pharmacol Exp Ther. 2004.
PMID: 15146030
Item in Clipboard
Cite
Cite